Close Menu

Neurological & Psychological Disorders

News on research and diagnostic developments in neuroscience.

The blood test runs on Abbott's i-Stat Alinity platform and returns results within 15 minutes, the company said.

The firm said that a US FDA clearance would broaden the adoption of its growing portfolio of diagnostic assays for Alzheimer's disease.

The company also announced it has received approval from California to offer the test, which it launched in October as a lab-developed test, in that state.

The ImmunArray spinoff said the financing will go toward a clinical trial and submission to FDA for its traumatic brain injury test.

Weill Cornell Medicine, New York-Presbyterian Hospital, and the New York Genome Center will join Illumina to sequence the genomes of thousands of patients.